Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an important complication in a substantial number of critically ill, hospitalized patients with COVID-19. Three groups of fungal pathogens cause co-infections in COVID-19: Aspe
induce COVID-19-associated mucormycosis (CAM) and also other fungal infections in immunocompromised patients. In addition, Mucorales produce a localized infection in the sinuses (paranasal sinuses), infection in orbit (sino-orbital), and infection in the orbit of the...
Fungal infections are among the major infections among immunocompromised patients [23]. A sharp increase in the incidence and mortality rates of fungal infections has been reported among COVID-19 patients, especially those who received immunosuppressive therapies or who have underlying conditions [24,25...
These infections involve different organs, such as the lungs, heart, and brain [4, 13]. The suggested factors that predispose patients with COVID-19 to invasive fungal infections include immune dysregulation, lymphopenia, inflammatory state, corticosteroid use, intubation and mechanical ventilation, ...
Most reports associating fungal infections with Covid-19 have been cases of invasive aspergillosis. Here we report a case of severe histoplasmosis and Covid-19 infections in an HIV patient in Rio Grande, Southern Brazil. Histoplasmosis must be included on the list of opportunist fungal co-...
Associated secondary fungal infections like mucormycosis have been observed amongst patients with COVID -19 infection. A sudden surge in the number of cases has been recorded in sync with the second wave of COVID-19 in India. Rhino-orbital-cerebral mucormycosis (RCOM) is aggressive, associated...
Pathogenesis of Respiratory Viral and Fungal Coinfections 2022, Clinical Microbiology Reviews Invasive fungal infections complicating covid-19: A narrative review 2021, Journal of Fungi Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021...
Severe COVID-19 hospitalized patients receiving long-term broad-spectrum antibiotics may also be prone to fungal infections of the digestive tract due to killing of commensal bacteria, resulting in diarrhea. Unfortunately, this area of fungal pathogenesis in COVID-19 is under-researched so far. At...
Invasive medical procedures are recognized as a risk factor for the development of both bacterial and fungal nosocomial infections [18]. The literature extensively describes how invasive medical devices breach mucosal or skin barriers, enabling pathogens to pass directly, thereby promoting nosocomial ...
In immunocompromised hosts, the main invasive fungal infections are Candidiasis, Aspergillosis, Mucormycosis and Cryptococcosis [35]. The unanswered pertinent observation herein is the extremely rare occurrence of other opportunistic infections usually expected in immunocompromised cases and the selective presenc...